Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-27 @ 10:44 PM
Study NCT ID:
NCT04975061
Status:
UNKNOWN
Last Update Posted:
2021-07-23
First Post:
2021-07-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Effectiveness，Safety，Thymic Cancer | View |
Keywords: